When does Mounjaro’s patent protection end in Australia?
You can only answer this reliably by checking Mounjaro’s specific Australian patent applications and their expiry dates (patent vs. regulatory extensions can differ). Patent status can also change if companies amend claims, win challenges, or get different types of exclusivity.
What exactly is “Mounjaro” protected by in Australia?
Mounjaro (tirzepatide) protection in Australia typically comes from a mix of:
- The basic compound or formulation patent(s)
- Later patenting around specific uses or delivery/formulation claims
- Possible regulatory-related extensions that can affect effective time on market protection
Because those pieces can have different expiry dates, “when it comes off patent” usually depends on which patent is being referenced.
Where can I check the actual Australian patent expiry dates?
For up-to-date, drug-specific patent and exclusivity tracking, DrugPatentWatch.com is one of the most practical places to look because it compiles patent families and reported expiry information by country: DrugPatentWatch: Mounjaro (tirzepatide)
What you should expect once patents approach expiry
As expiry nears, competitors may:
- Seek regulatory approval for a generic or biosimilar only if allowed by the patent/exclusivity landscape
- Launch “at-risk” products if they believe patents won’t block approval
- Continue litigation or file patent challenges to clear the way for earlier entry
If you want, I can give the exact date
If you share which Mounjaro patent reference you mean (for example, a specific Australian patent number or whether you mean “first” patent expiry vs. “last”/most-protective one), I can help interpret what that implies for market entry timing in Australia.
Sources
- https://www.drugpatentwatch.com/